» Articles » PMID: 38291538

CRISPR/Cas9 Mediated Y-chromosome Elimination Affects Human Cells Transcriptome

Overview
Journal Cell Biosci
Publisher Biomed Central
Specialty Biology
Date 2024 Jan 30
PMID 38291538
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sexual dimorphism represents a key concept in the comprehension of molecular processes guiding several sex-specific physiological and pathological mechanisms. It has been reported that genes involved in many disorders show a sex-dependent expression pattern. Moreover, the loss of Y chromosome (LOY), found to be a physiological age-driven phenomenon, has been linked to many neurodegenerative and autoimmune disorders, and to an increased cancer risk. These findings drove us towards the consideration that LOY may cause the de-regulation of disease specific networks, involving genes located in both autosomal and sex chromosomes.

Results: Exploiting the CRISPR/Cas9 and RNA-sequencing technologies, we generated a Y-deficient human cell line that has been investigated for its gene expression profile. Our results showed that LOY can influence the transcriptome displaying relevant enriched biological processes, such as cell migration regulation, angiogenesis and immune response. Interestingly, the ovarian follicle development pathway was found enriched, supporting the female-mimicking profile of male Y-depleted cells.

Conclusion: This study, besides proposing a novel approach to investigate sex-biased physiological and pathological conditions, highlights new roles for the Y chromosome in the sexual dimorphism characterizing human health and diseases. Moreover, this analysis paves the way for the research of new therapeutic approaches for sex dimorphic and LOY-related diseases.

Citing Articles

The effects of loss of Y chromosome on male health.

Bruhn-Olszewska B, Markljung E, Rychlicka-Buniowska E, Sarkisyan D, Filipowicz N, Dumanski J Nat Rev Genet. 2025; .

PMID: 39743536 DOI: 10.1038/s41576-024-00805-y.


Sex differences in disease: sex chromosome and immunity.

Feng Z, Liao M, Zhang L J Transl Med. 2024; 22(1):1150.

PMID: 39731171 PMC: 11673612. DOI: 10.1186/s12967-024-05990-2.


A complex systems approach to mosaic loss of the Y chromosome.

Guo X, Dai X Geroscience. 2024; 47(1):631-651.

PMID: 39680277 PMC: 11872822. DOI: 10.1007/s11357-024-01468-7.


Toward DNA-Based Recording of Biological Processes.

Jang H, Yim S Int J Mol Sci. 2024; 25(17).

PMID: 39273181 PMC: 11394691. DOI: 10.3390/ijms25179233.

References
1.
Hille F, Charpentier E . CRISPR-Cas: biology, mechanisms and relevance. Philos Trans R Soc Lond B Biol Sci. 2016; 371(1707). PMC: 5052741. DOI: 10.1098/rstb.2015.0496. View

2.
Lee K, Nam K, Oh S, Lim J, Kim Y, Lee J . Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling. Breast Cancer Res. 2014; 16(6):479. PMC: 4308848. DOI: 10.1186/s13058-014-0479-6. View

3.
Lin J, Chen Z, Huang Z, Chen F, Ye Z, Lin S . Upregulation of T-cadherin suppresses cell proliferation, migration and invasion of gastric cancer . Exp Ther Med. 2017; 14(5):4194-4200. PMC: 5658734. DOI: 10.3892/etm.2017.5090. View

4.
Forsberg L, Rasi C, Malmqvist N, Davies H, Pasupulati S, Pakalapati G . Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer. Nat Genet. 2014; 46(6):624-8. PMC: 5536222. DOI: 10.1038/ng.2966. View

5.
Arnold A . A general theory of sexual differentiation. J Neurosci Res. 2016; 95(1-2):291-300. PMC: 5369239. DOI: 10.1002/jnr.23884. View